Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.

The promoter of the human dihydrofolate reductase (DHFR) gene contains two consensus binding sites for the DNA binding protein Sp1. DNAse protection and gel mobility shift assays demonstrate binding of recombinant Sp1 to both decanucleotide Sp1 binding sequences which are located 49 and 14 base pair...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Invest
Autors principals:	Blume, S W, Snyder, R C, Ray, R, Thomas, S, Koller, C A, Miller, D M
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Clinical Investigation 1991
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1834700/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115474
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!